Non-steroidal anti-infl ammatory agents (NSAIDs), steroids and representatives of other pharmacological groups [1, 2] are widely used for pharmacological regulation of infl ammation. However, their anti-infl ammatory effects are accompanied by serious adverse reactions [3, 4] . There was a hope that newer NSAIDs, selective inhibitors of COX-2, would be safer, but their longer-term use appeared to cause an increased risk of heart attacks and stroke [5] . Carrageenan rat paw oedema model is traditionally used for search and development of new NSAIDs with assessment of effects after 3 to 5 hours after oedema induction [6, 7] , neglecting longer-term effects [8] .
